Effects of Zolpidem CR® in Sleep and Heart Recovery in Cardiac Intensive Care Unit Patients

• Status: Unknown status
• Trial end date: 2014-01-01
• Target enrollment: 0
• Participant gender: All

Summary

A double blind, randomized, placebo-controlled study will be conducted in cardiac ICU patients who had been diagnosed with acute coronary syndrome, using a sleep promoting drug (zolpidem controlled release).

The study hypothesis is that sleeping better can improve the heart recovery in patients with a diagnosis of acute coronary syndrome.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Associação Fundo de Incentivo à Pesquisa
• Collaborator: Conselho Nacional de Desenvolvimento Científico e Tecnológico
• Treatments: Zolpidem

Criteria

Inclusion Criteria:

• Patients from 18 to 75 years of age

• Diagnosis of acute coronary syndrome

• Capable of swallowing pills

• Capable of filling in the questionaires

Exclusion Criteria:

• Class IV heart failure according to the New York heart association functional class,

• Patients in a coma

• Patients receiving mechanical ventilation

• Patients who regularly use benzodiazepines or other medications for inducing sleep